Mesoblast

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Mesoblast and other ETFs, options, and stocks.

About MESO

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. 

CEO
Silviu Itescu
CEOSilviu Itescu
Employees
83
Employees83
Headquarters
Melbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded
2004
Founded2004
Employees
83
Employees83

MESO Key Statistics

Market cap
712.13M
Market cap712.13M
Price-Earnings ratio
-5.87
Price-Earnings ratio-5.87
Dividend yield
Dividend yield
Average volume
343.23K
Average volume343.23K
High today
$6.36
High today$6.36
Low today
$6.00
Low today$6.00
Open price
$6.04
Open price$6.04
Volume
324.69K
Volume324.69K
52 Week high
$10.24
52 Week high$10.24
52 Week low
$1.61
52 Week low$1.61
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.